Globus Medical, Inc.
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprisin…
Medical - Devices
US, Audubon [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Current Ratio | -52.36 | 2.33 | 4.88 | |
| Debt/Assets | n.A. | n.A. | n.A. | |
| Debt/Equity | n.A. | n.A. | n.A. | |
| Net Debt/EBITDA | 209.81 | 1.77 | 0.57 | |
| Naive Interpretation | member | |||
2
Per Share
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | -0.06 | 28.98 | 29.00 | |
| Cash | -14.53 | 3.21 | 3.76 | |
| Capex | -27.18 | -0.21 | -0.17 | |
| Free Cash Flow | -70.34 | 0.18 | 0.59 | |
| Revenue | 0.24 | 4.48 | 4.47 | |
| Naive Interpretation | member | |||
3
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Margin | -2.87 | 0.55 | 0.57 | |
| Operating Margin | 322.90 | 0.07 | 0.02 | |
| ROA | -51.30 | < 0.005 | < 0.005 | |
| ROE | -51.75 | < 0.005 | < 0.005 | |
| ROIC | 472.59 | < 0.005 | < 0.005 | |
| Naive Interpretation | member | |||
4
Valuation
The "Valuation Entry" for the Focus of GMED is permitted for members.
5
Growth
The "Growth Entry" for the Focus of GMED is permitted for members.
6
Leverage & Liquidity